EcoR1 Capital as of Sept. 30, 2015
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 25 positions in its portfolio as reported in the September 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Fibrogen | 12.3 | $27M | 1.2M | 21.92 | |
| Atara Biotherapeutics | 11.5 | $25M | 804k | 31.44 | |
| Array Biopharma Note (Principal) | 10.1 | $22M | 23M | 0.99 | |
| Retrophin | 9.3 | $20M | 1.0M | 20.26 | |
| Epizyme | 8.7 | $19M | 1.5M | 12.86 | |
| Assembly Biosciences | 8.2 | $18M | 1.9M | 9.56 | |
| Kite Pharma | 7.1 | $16M | 281k | 55.68 | |
| Flex Pharma | 5.1 | $11M | 934k | 12.01 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 4.7 | $10M | 465k | 22.11 | |
| Atyr Pharma Inc Common Stock Usd 0.001 | 3.9 | $8.6M | 841k | 10.26 | |
| Nabriva Therapeutics Sponsored Adr | 3.6 | $7.9M | 836k | 9.50 | |
| Kindred Biosciences | 3.1 | $6.9M | 1.3M | 5.20 | |
| Genvec | 2.1 | $4.6M | 2.0M | 2.31 | |
| Celladon | 1.4 | $3.0M | 2.8M | 1.05 | |
| Oncothyreon | 1.2 | $2.6M | 944k | 2.74 | |
| Akari Therapeutics Sponsored Adr | 1.1 | $2.4M | 101k | 24.00 | |
| Forward Pharma A/s Sponsored Adr | 1.1 | $2.4M | 102k | 23.56 | |
| Five Prime Therapeutics | 1.0 | $2.3M | 149k | 15.39 | |
| Calithera Biosciences | 1.0 | $2.3M | 416k | 5.43 | |
| Gilead Sciences Inc option Call Option | 1.0 | $2.1M | 3.3k | 659.91 | |
| Orexigen Therapeutics | 0.9 | $2.0M | 938k | 2.11 | |
| Qlt | 0.8 | $1.7M | 639k | 2.66 | |
| VALEANT PHARMACEUTICALS Inte call Call Option | 0.6 | $1.3M | 1.3k | 1064.82 | |
| Catalyst Biosciences | 0.1 | $261k | 56k | 4.66 | |
| Regulus Therapeutics Call Option | 0.0 | $35k | 1.3k | 27.34 |
